I am a
Home I AM A Search Login

Papers of the Week

Papers: 10 Sep 2022 - 16 Sep 2022

Human Studies

2022 Sep 13

Eur J Neurol

Maintenance of response and predictive factors of one-year GalcanezumAb treatment in Real Life migraine patients in ITaly: the multicenter prospective cohort GARLIT study.


Vernieri F, Brunelli N, Marcosano M, Aurilia C, Egeo G, Lovati C, Favoni V, Perrotta A, Maestrini I, Rao R, d'Onofrio L, Finocchi C, Aguggia M, Bono F, Ranieri A, Albanese M, Di Piero V, Cevoli S, Altamura C, Barbanti P
Eur J Neurol. 2022 Sep 13.
PMID: 36097739.


To evaluate the one-year effectiveness and tolerability of galcanezumab in real life and the prognostic indicators of persistent response.